Justin Zelin, BTIG Biotechnology Analyst, will be speaking during the Investment & Strategy Bootcamp session at the 9th Annual CAR-TCR Summit on Tuesday, September 17th, at 3:30pm ET. Discussion topics will include trends and themes in the investment landscape for cell therapy companies. To learn more about the event, please visit https://lnkd.in/evTd45z3. #BTIG #BTIGResearch #CARTCRSummit #celltherapy #biotechnology
BTIG’s Post
More Relevant Posts
-
Are you ready to start your journey with RNAscope by exploring its powerful molecular imaging capabilities and unraveling gene expression patterns with precision and clarity?
We love it Brandon James from HudsonAlpha Institute for Biotechnology - your beautiful #RNAscope Multiplex V2 image is out of this world! Congratulations on being our June Winner - we hope to see more #ArtofRNAscope submitted for the 2025 calendar! Submit your #spatialmultiomics image here: https://lnkd.in/gM4Wyvkm
To view or add a comment, sign in
-
The Next Generation Sequencing (NGS) Market is expected to reach $27.5 billion by 2030, at a CAGR of 15.8% from 2023–2030. Stellar Growth in Next Generation Sequencing ✨️ Next Generation Sequencing is one of the most important application in Biotechnology
To view or add a comment, sign in
-
BRAIN Biotech AG, our parent company, released their annual report FY 2022/23. Read the highlights from the BRAIN Biotech Group's past fiscal year below https://lnkd.in/gkm9fQwP #Biotechnology #AnnualReport #BRAINBiotechGroup
To view or add a comment, sign in
-
Struggling to identify irregularities in your cell cultures? We know how important a healthy cell culture is for successful outcomes in research and production processes. One key feature by using our cell counter NucleoCounter® NC-202™ is the DebrisIndex™ monitor tool, which provides insights into the amount of debris present in your sample relative to cell concentration, allowing researchers and manufacturers to ensure the quality and viability of the cells in your cell culture work. Let’s work together to accelerate the development and production of life-saving medications using innovative biotechnology. Learn more about the DebrisIndex™ here: https://okt.to/9m7uP5
To view or add a comment, sign in
-
It's always great to see the real world applications of our instruments, and even more so to hear how much our customers enjoy using them everyday... The MA900 cell sorter is a new addition at the University of Warwick, where Dr. Steven Servin runs the facility. When asked about his experience of the MA900, Steven said: "I love that it is very user friendly, fast and reliable. I also love the precision of sorting". As always, do let me know if you are interested in learning more about this feature packed, multi-application sorter or our pioneering spectral instruments. #SonyBiotechnology #flowcytometry #cellsorting
Guess what I'm sorting today people! I'll give you a clue, it's eukaryotic! #flowcytometry #FACS Sony Biotechnology Inc.
To view or add a comment, sign in
-
Nucleic Acid Isolation and Purification Market worth $9.4 billion by 2028 Download PDF Brochure:-https://lnkd.in/dGfFTP3A The global nucleic acid isolation and purification market in terms of revenue was estimated to be worth $6.4 billion in 2023 and is poised to reach $9.4 billion by 2028, growing at a CAGR of 8.1% from 2023 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific QIAGEN Merck Wohlfahrtsstiftung der F. Hoffmann-La Roche AG Promega Corporation Agilent Technologies, Danaher Corporation Bio-Rad Laboratories, Illumina, Takara Bio USA, Inc. New England Biolabs abcam Kilpest India Ltd. Apical Scientific Sdn Bhd Endress+Hauser Group Genaxxon bioscience GmbH LGC Biosearch Technologies Zymo Research Corp Norgen Biotek Omega Bio-tek, TIANGEN BIOTECH (BEIJING)CO LTD. AutoGen, Inc. PCR Biosystems Biogenuix Medsystems Pvt Ltd #nucleicacid #molecularbiology #dnaextraction #rnaisolation #genomics
To view or add a comment, sign in
-
Bud-wiser: DOD Backs A-Alpha Bio for Biothreat Preparation https://lnkd.in/gwVD-TNM A-Alpha Bio, a Seattle-based biotechnology company, announced the Department of Defense has awarded the company another $14.5M to accelerate its antibody discovery and optimize for biothreats. According to A-Alpha Bio cofounder and CEO, David Younger, PHD, “We’ve measured 10 million interactions in this collaboration and have focused so far on three pathogenic families. This extension of funding will allow us to really broaden both our potential impact on pandemic preparedness and our interest in training more generalizable models. Having an interaction space that covers more pathogen diversity is exactly what we’re interested in doing.” The post Bud-wiser: DOD Backs A-Alpha Bio for Biothreat Preparation appeared first on Life Science Washington . Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Bud-wiser: DOD Backs A-Alpha Bio for Biothreat Preparation
https://wobn.org
To view or add a comment, sign in
-
Nucleic Acid Isolation and Purification Market worth $9.4 billion by 2028 Download PDF Brochure:-https://lnkd.in/dVuWnMQS The global nucleic acid isolation and purification market in terms of revenue was estimated to be worth $6.4 billion in 2023 and is poised to reach $9.4 billion by 2028, growing at a CAGR of 8.1% from 2023 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific QIAGEN Merck Wohlfahrtsstiftung der F. Hoffmann-La Roche AG Promega Corporation Agilent Technologies, Danaher Corporation Bio-Rad Laboratories, Illumina, Takara Bio USA, Inc. New England Biolabs abcam Kilpest India Ltd. Apical Scientific Sdn Bhd Endress+Hauser Group Genaxxon bioscience GmbH LGC Biosearch Technologies Zymo Research Corp Norgen Biotek. Omega Bio-tek, TIANGEN BIOTECH (BEIJING)CO LTD. AutoGen, Inc. PCR Biosystems Biogenuix Medsystems Pvt Ltd #nucleicacidpurification #genomics #molecularbiology #dnaextraction #rnaisolation
To view or add a comment, sign in
-
New Blog Alert!! On our new Research Updates Blog, we will be sharing layperson-friendly summaries of recent publications about DYNC1H1, dynein, and biotechnology research. This first post highlights results of the Diagnostic Odyssey Survey. This was only possible because of patients in our Contact Registry filling out the survey. Haven’t registered yet? Do so at: dync1h1.org/registry. Thank you to those who participated! If you forgot to complete the survey, it’s not too late! Check out the blog at: https://lnkd.in/ejHM4ipF #dync1h1 #researchupdates #raredisease
To view or add a comment, sign in
-
Nucleic Acid Isolation and Purification Market worth $9.4 billion by 2028 Download PDF Brochure:-https://lnkd.in/dJPZBCRT The global nucleic acid isolation and purification market in terms of revenue was estimated to be worth $6.4 billion in 2023 and is poised to reach $9.4 billion by 2028, growing at a CAGR of 8.1% from 2023 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific QIAGEN Merck Wohlfahrtsstiftung der F. Hoffmann-La Roche AG Promega Corporation Agilent Technologies, Danaher Corporation Bio-Rad Laboratories, Illumina. Takara Bio Inc. New England Biolabs abcam Kilpest India Ltd. Apical Scientific Sdn Bhd Genaxxon bioscience GmbH LGC Biosearch Technologies Zymo Research Corp Norgen Biotek Omega Bio-tek, TIANGEN BIOTECH (BEIJING)CO LTD. AutoGen, Inc. PCR Biosystems Biogenuix Medsystems Pvt Ltd #nucleicacidpurification #molecularbiology #genomics #dnaextraction #rnaisolation
To view or add a comment, sign in
58,457 followers
Managing Director at Lucid Capital Markets
1moCongrats, Justin! That's awesome!